Global and Japan Microbiome Therapies Market Size, Status and Forecast 2023-2027

Report ID: 1127399 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Microbiome Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Bacteria
        1.2.3 Fungi
        1.2.4 Virus
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Microbiome Therapies Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Testing Centres
        1.3.3 Research Labs
        1.3.4 Horticulture
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Microbiome Therapies Market Perspective (2016-2027)
    2.2 Microbiome Therapies Growth Trends by Regions
        2.2.1 Microbiome Therapies Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Microbiome Therapies Historic Market Share by Regions (2016-2021)
        2.2.3 Microbiome Therapies Forecasted Market Size by Regions (2022-2027)
    2.3 Microbiome Therapies Industry Dynamic
        2.3.1 Microbiome Therapies Market Trends
        2.3.2 Microbiome Therapies Market Drivers
        2.3.3 Microbiome Therapies Market Challenges
        2.3.4 Microbiome Therapies Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Microbiome Therapies Players by Revenue
        3.1.1 Global Top Microbiome Therapies Players by Revenue (2016-2021)
        3.1.2 Global Microbiome Therapies Revenue Market Share by Players (2016-2021)
    3.2 Global Microbiome Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Microbiome Therapies Revenue
    3.4 Global Microbiome Therapies Market Concentration Ratio
        3.4.1 Global Microbiome Therapies Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Microbiome Therapies Revenue in 2020
    3.5 Microbiome Therapies Key Players Head office and Area Served
    3.6 Key Players Microbiome Therapies Product Solution and Service
    3.7 Date of Enter into Microbiome Therapies Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Microbiome Therapies Breakdown Data by Type
    4.1 Global Microbiome Therapies Historic Market Size by Type (2016-2021)
    4.2 Global Microbiome Therapies Forecasted Market Size by Type (2022-2027)

5 Microbiome Therapies Breakdown Data by Application
    5.1 Global Microbiome Therapies Historic Market Size by Application (2016-2021)
    5.2 Global Microbiome Therapies Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Microbiome Therapies Market Size (2016-2027)
    6.2 North America Microbiome Therapies Market Size by Type
        6.2.1 North America Microbiome Therapies Market Size by Type (2016-2021)
        6.2.2 North America Microbiome Therapies Market Size by Type (2022-2027)
        6.2.3 North America Microbiome Therapies Market Size by Type (2016-2027)
    6.3 North America Microbiome Therapies Market Size by Application
        6.3.1 North America Microbiome Therapies Market Size by Application (2016-2021)
        6.3.2 North America Microbiome Therapies Market Size by Application (2022-2027)
        6.3.3 North America Microbiome Therapies Market Size by Application (2016-2027)
    6.4 North America Microbiome Therapies Market Size by Country
        6.4.1 North America Microbiome Therapies Market Size by Country (2016-2021)
        6.4.2 North America Microbiome Therapies Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Microbiome Therapies Market Size (2016-2027)
    7.2 Europe Microbiome Therapies Market Size by Type
        7.2.1 Europe Microbiome Therapies Market Size by Type (2016-2021)
        7.2.2 Europe Microbiome Therapies Market Size by Type (2022-2027)
        7.2.3 Europe Microbiome Therapies Market Size by Type (2016-2027)
    7.3 Europe Microbiome Therapies Market Size by Application
        7.3.1 Europe Microbiome Therapies Market Size by Application (2016-2021)
        7.3.2 Europe Microbiome Therapies Market Size by Application (2022-2027)
        7.3.3 Europe Microbiome Therapies Market Size by Application (2016-2027)
    7.4 Europe Microbiome Therapies Market Size by Country
        7.4.1 Europe Microbiome Therapies Market Size by Country (2016-2021)
        7.4.2 Europe Microbiome Therapies Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Microbiome Therapies Market Size (2016-2027)
    8.2 Asia-Pacific Microbiome Therapies Market Size by Type
        8.2.1 Asia-Pacific Microbiome Therapies Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Microbiome Therapies Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Microbiome Therapies Market Size by Type (2016-2027)
    8.3 Asia-Pacific Microbiome Therapies Market Size by Application
        8.3.1 Asia-Pacific Microbiome Therapies Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Microbiome Therapies Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Microbiome Therapies Market Size by Application (2016-2027)
    8.4 Asia-Pacific Microbiome Therapies Market Size by Region
        8.4.1 Asia-Pacific Microbiome Therapies Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Microbiome Therapies Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Microbiome Therapies Market Size (2016-2027)
    9.2 Latin America Microbiome Therapies Market Size by Type
        9.2.1 Latin America Microbiome Therapies Market Size by Type (2016-2021)
        9.2.2 Latin America Microbiome Therapies Market Size by Type (2022-2027)
        9.2.3 Latin America Microbiome Therapies Market Size by Type (2016-2027)
    9.3 Latin America Microbiome Therapies Market Size by Application
        9.3.1 Latin America Microbiome Therapies Market Size by Application (2016-2021)
        9.3.2 Latin America Microbiome Therapies Market Size by Application (2022-2027)
        9.3.3 Latin America Microbiome Therapies Market Size by Application (2016-2027)
    9.4 Latin America Microbiome Therapies Market Size by Country
        9.4.1 Latin America Microbiome Therapies Market Size by Country (2016-2021)
        9.4.2 Latin America Microbiome Therapies Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Microbiome Therapies Market Size (2016-2027)
    10.2 Middle East & Africa Microbiome Therapies Market Size by Type
        10.2.1 Middle East & Africa Microbiome Therapies Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Microbiome Therapies Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Microbiome Therapies Market Size by Type (2016-2027)
    10.3 Middle East & Africa Microbiome Therapies Market Size by Application
        10.3.1 Middle East & Africa Microbiome Therapies Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Microbiome Therapies Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Microbiome Therapies Market Size by Application (2016-2027)
    10.4 Middle East & Africa Microbiome Therapies Market Size by Country
        10.4.1 Middle East & Africa Microbiome Therapies Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Microbiome Therapies Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 uBiome
        11.1.1 uBiome Company Details
        11.1.2 uBiome Business Overview
        11.1.3 uBiome Microbiome Therapies Introduction
        11.1.4 uBiome Revenue in Microbiome Therapies Business (2016-2021)
        11.1.5 uBiome Recent Development
    11.2 Evolve BioSystems
        11.2.1 Evolve BioSystems Company Details
        11.2.2 Evolve BioSystems Business Overview
        11.2.3 Evolve BioSystems Microbiome Therapies Introduction
        11.2.4 Evolve BioSystems Revenue in Microbiome Therapies Business (2016-2021)
        11.2.5 Evolve BioSystems Recent Development
    11.3 Indigo Agriculture
        11.3.1 Indigo Agriculture Company Details
        11.3.2 Indigo Agriculture Business Overview
        11.3.3 Indigo Agriculture Microbiome Therapies Introduction
        11.3.4 Indigo Agriculture Revenue in Microbiome Therapies Business (2016-2021)
        11.3.5 Indigo Agriculture Recent Development
    11.4 Pivot Bio
        11.4.1 Pivot Bio Company Details
        11.4.2 Pivot Bio Business Overview
        11.4.3 Pivot Bio Microbiome Therapies Introduction
        11.4.4 Pivot Bio Revenue in Microbiome Therapies Business (2016-2021)
        11.4.5 Pivot Bio Recent Development
    11.5 Concentric Ag
        11.5.1 Concentric Ag Company Details
        11.5.2 Concentric Ag Business Overview
        11.5.3 Concentric Ag Microbiome Therapies Introduction
        11.5.4 Concentric Ag Revenue in Microbiome Therapies Business (2016-2021)
        11.5.5 Concentric Ag Recent Development
    11.6 Epibiome
        11.6.1 Epibiome Company Details
        11.6.2 Epibiome Business Overview
        11.6.3 Epibiome Microbiome Therapies Introduction
        11.6.4 Epibiome Revenue in Microbiome Therapies Business (2016-2021)
        11.6.5 Epibiome Recent Development
    11.7 CosmosID
        11.7.1 CosmosID Company Details
        11.7.2 CosmosID Business Overview
        11.7.3 CosmosID Microbiome Therapies Introduction
        11.7.4 CosmosID Revenue in Microbiome Therapies Business (2016-2021)
        11.7.5 CosmosID Recent Development
    11.8 Human Longevity
        11.8.1 Human Longevity Company Details
        11.8.2 Human Longevity Business Overview
        11.8.3 Human Longevity Microbiome Therapies Introduction
        11.8.4 Human Longevity Revenue in Microbiome Therapies Business (2016-2021)
        11.8.5 Human Longevity Recent Development
    11.9 Ajinomoto Cambrooke
        11.9.1 Ajinomoto Cambrooke Company Details
        11.9.2 Ajinomoto Cambrooke Business Overview
        11.9.3 Ajinomoto Cambrooke Microbiome Therapies Introduction
        11.9.4 Ajinomoto Cambrooke Revenue in Microbiome Therapies Business (2016-2021)
        11.9.5 Ajinomoto Cambrooke Recent Development
    11.10 AnimalBiome
        11.10.1 AnimalBiome Company Details
        11.10.2 AnimalBiome Business Overview
        11.10.3 AnimalBiome Microbiome Therapies Introduction
        11.10.4 AnimalBiome Revenue in Microbiome Therapies Business (2016-2021)
        11.10.5 AnimalBiome Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Microbiome Therapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Bacteria
    Table 3. Key Players of Fungi
    Table 4. Key Players of Virus
    Table 5. Key Players of Others
    Table 6. Global Microbiome Therapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Microbiome Therapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Microbiome Therapies Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Microbiome Therapies Market Share by Regions (2016-2021)
    Table 10. Global Microbiome Therapies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Microbiome Therapies Market Share by Regions (2022-2027)
    Table 12. Microbiome Therapies Market Trends
    Table 13. Microbiome Therapies Market Drivers
    Table 14. Microbiome Therapies Market Challenges
    Table 15. Microbiome Therapies Market Restraints
    Table 16. Global Microbiome Therapies Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Microbiome Therapies Market Share by Players (2016-2021)
    Table 18. Global Top Microbiome Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiome Therapies as of 2020)
    Table 19. Ranking of Global Top Microbiome Therapies Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Microbiome Therapies Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Microbiome Therapies Product Solution and Service
    Table 23. Date of Enter into Microbiome Therapies Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Microbiome Therapies Revenue Market Share by Type (2016-2021)
    Table 27. Global Microbiome Therapies Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Microbiome Therapies Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Microbiome Therapies Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Microbiome Therapies Revenue Market Share by Application (2016-2021)
    Table 31. Global Microbiome Therapies Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Microbiome Therapies Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Microbiome Therapies Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Microbiome Therapies Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Microbiome Therapies Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Microbiome Therapies Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Microbiome Therapies Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Microbiome Therapies Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Microbiome Therapies Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Microbiome Therapies Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Microbiome Therapies Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Microbiome Therapies Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Microbiome Therapies Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Microbiome Therapies Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Microbiome Therapies Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Microbiome Therapies Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Microbiome Therapies Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Microbiome Therapies Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Microbiome Therapies Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Microbiome Therapies Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Microbiome Therapies Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Microbiome Therapies Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Microbiome Therapies Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Microbiome Therapies Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Microbiome Therapies Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Microbiome Therapies Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Microbiome Therapies Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. uBiome Company Details
    Table 64. uBiome Business Overview
    Table 65. uBiome Microbiome Therapies Product
    Table 66. uBiome Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
    Table 67. uBiome Recent Development
    Table 68. Evolve BioSystems Company Details
    Table 69. Evolve BioSystems Business Overview
    Table 70. Evolve BioSystems Microbiome Therapies Product
    Table 71. Evolve BioSystems Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
    Table 72. Evolve BioSystems Recent Development
    Table 73. Indigo Agriculture Company Details
    Table 74. Indigo Agriculture Business Overview
    Table 75. Indigo Agriculture Microbiome Therapies Product
    Table 76. Indigo Agriculture Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
    Table 77. Indigo Agriculture Recent Development
    Table 78. Pivot Bio Company Details
    Table 79. Pivot Bio Business Overview
    Table 80. Pivot Bio Microbiome Therapies Product
    Table 81. Pivot Bio Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
    Table 82. Pivot Bio Recent Development
    Table 83. Concentric Ag Company Details
    Table 84. Concentric Ag Business Overview
    Table 85. Concentric Ag Microbiome Therapies Product
    Table 86. Concentric Ag Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
    Table 87. Concentric Ag Recent Development
    Table 88. Epibiome Company Details
    Table 89. Epibiome Business Overview
    Table 90. Epibiome Microbiome Therapies Product
    Table 91. Epibiome Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
    Table 92. Epibiome Recent Development
    Table 93. CosmosID Company Details
    Table 94. CosmosID Business Overview
    Table 95. CosmosID Microbiome Therapies Product
    Table 96. CosmosID Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
    Table 97. CosmosID Recent Development
    Table 98. Human Longevity Company Details
    Table 99. Human Longevity Business Overview
    Table 100. Human Longevity Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
    Table 101. Human Longevity Recent Development
    Table 102. Ajinomoto Cambrooke Company Details
    Table 103. Ajinomoto Cambrooke Business Overview
    Table 104. Ajinomoto Cambrooke Microbiome Therapies Product
    Table 105. Ajinomoto Cambrooke Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
    Table 106. Ajinomoto Cambrooke Recent Development
    Table 107. AnimalBiome Company Details
    Table 108. AnimalBiome Business Overview
    Table 109. AnimalBiome Microbiome Therapies Product
    Table 110. AnimalBiome Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
    Table 111. AnimalBiome Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Microbiome Therapies Market Share by Type: 2020 VS 2027
    Figure 2. Bacteria Features
    Figure 3. Fungi Features
    Figure 4. Virus Features
    Figure 5. Others Features
    Figure 6. Global Microbiome Therapies Market Share by Application: 2020 VS 2027
    Figure 7. Testing Centres Case Studies
    Figure 8. Research Labs Case Studies
    Figure 9. Horticulture Case Studies
    Figure 10. Others Case Studies
    Figure 11. Microbiome Therapies Report Years Considered
    Figure 12. Global Microbiome Therapies Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Microbiome Therapies Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Microbiome Therapies Market Share by Regions: 2020 VS 2027
    Figure 15. Global Microbiome Therapies Market Share by Regions (2022-2027)
    Figure 16. Global Microbiome Therapies Market Share by Players in 2020
    Figure 17. Global Top Microbiome Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiome Therapies as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Microbiome Therapies Revenue in 2020
    Figure 19. Global Microbiome Therapies Revenue Market Share by Type (2016-2021)
    Figure 20. Global Microbiome Therapies Revenue Market Share by Type (2022-2027)
    Figure 21. North America Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Microbiome Therapies Market Share by Type (2016-2027)
    Figure 23. North America Microbiome Therapies Market Share by Application (2016-2027)
    Figure 24. North America Microbiome Therapies Market Share by Country (2016-2027)
    Figure 25. United States Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Microbiome Therapies Market Share by Type (2016-2027)
    Figure 29. Europe Microbiome Therapies Market Share by Application (2016-2027)
    Figure 30. Europe Microbiome Therapies Market Share by Country (2016-2027)
    Figure 31. Germany Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Microbiome Therapies Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Microbiome Therapies Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Microbiome Therapies Market Share by Region (2016-2027)
    Figure 41. China Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Microbiome Therapies Market Share by Type (2016-2027)
    Figure 49. Latin America Microbiome Therapies Market Share by Application (2016-2027)
    Figure 50. Latin America Microbiome Therapies Market Share by Country (2016-2027)
    Figure 51. Mexico Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Microbiome Therapies Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Microbiome Therapies Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Microbiome Therapies Market Share by Country (2016-2027)
    Figure 57. Turkey Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. uBiome Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
    Figure 61. Evolve BioSystems Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
    Figure 62. Indigo Agriculture Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
    Figure 63. Pivot Bio Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
    Figure 64. Concentric Ag Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
    Figure 65. Epibiome Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
    Figure 66. CosmosID Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
    Figure 67. Human Longevity Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
    Figure 68. Ajinomoto Cambrooke Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
    Figure 69. AnimalBiome Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
uBiome
Evolve BioSystems
Indigo Agriculture
Pivot Bio
Concentric Ag
Epibiome
CosmosID
Human Longevity
Ajinomoto Cambrooke
AnimalBiome
Frequently Asked Questions
Microbiome Therapies report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Microbiome Therapies report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Microbiome Therapies report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Sedation Therapy

Global Sedation Therapy Scope and Market Size
Sedation Therapy market is segmented  ... Read More

Sexual Lubricant

Sexual Lubricant market is segmented by region (country), players, by Type, and by Application. P ... Read More